Showing results 21 to 40 of 918
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2010 | A novel animal model of graded neuropathic pain: Utility to investigate mechanisms of population heterogeneity | Grace, P.; Hutchinson, M.; Manavis, J.; Somogyi, A.; Rolan, P. |
| 2009 | A Peptide Antagonist of the TLR4-MD2 Interaction | Slivka, P.; Shridhar, M.; Lee, G.; Sammond, D.; Hutchinson, M.; Martinko, A.; Buchanan, M.; Sholar, P.; Kearney, J.; Harrison, J.; Watkins, L.; Yin, H. |
| 2014 | A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors | Chiorean, E.; Sweeney, C.; Youssoufian, H.; Qin, A.; Dontabhaktuni, A.; Loizos, N.; Nippgen, J.; Amato, R. |
| 2002 | A phase I study of the GM-CSF antagonist E21R | Olver, I.; Hercus, T.; Lopez, A.; Vadas, M.; Somogyi, A.; Doyle, I.; Foster, D.; Keefe, D.; Taylor, A.; Brown, M.; To, L.; Cole, J.; Rawling, T.; Cambareri, B.; Myers, M.; Olszewski, N.; Bastiras, S.; Senn, C.; Hey, A.; Verma, M.; et al. |
| 2003 | A placebo-controlled pharmacodynamic and pharmacokinetic interaction study between tamsulosin and acenocoumarol | Rolan, P.; Terpstra, I.; Clarke, C.; Mullins, F.; Visser, J. |
| 2008 | A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer | Rokavec, M.; Schroth, W.; Amaral, S.; Fritz, P.; Antoniadou, L.; Glavac, D.; Simon, W.; Schwab, M.; Eichelbaum, M.; Brauch, H. |
| 2009 | A possible link between iron deficiency and gastrointestinal carcinogenesis | Pra, D.; Rech Franke, S.; Pegas Henriques, J.; Fenech, M. |
| 2016 | A prospective open clinical trial of a proton pump inhibitor, elimination diet and/or budesonide for eosinophilic oesophagitis | Philpott, H.; Nandurkar, S.; Royce, S.; Thien, F.; Gibson, P. |
| 2016 | A quantitative review and meta-models of the variability and factors affecting oral drug absorption-Part I: gastrointestinal pH | Abuhelwa, A.; Foster, D.; Upton, R. |
| 2016 | A quantitative review and meta-models of the variability and factors affecting oral drug absorption-Part II: gastrointestinal transit time | Abuhelwa, A.; Foster, D.; Upton, R. |
| 2013 | A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence | Lintzeris, N.; Leung, S.; Dunlop, A.; Larance, B.; White, N.; Rivas, G.; Holland, R.; Degenhardt, L.; Muhleisen, P.; Hurley, M.; Ali, R. |
| 2012 | A randomized controlled trial of a brief intervention for illicit drugs linked to the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in clients recruited from primary health-care settings in four countries | Humeniuk, R.; Ali, R.; Babor, T.; Formigoni, M.; Boerngen de Lacerda, R.; Ling, W.; McRee, B.; Newcombe, D.; Pal, H.; Poznyak, V.; Simon, S.; Vendetti, J. |
| 2004 | A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza | Latte, G.; Taverner, D.; Slobodian, P.; Shakib, S. |
| 1999 | A review of biological indicators of illicit drug use, practical considerations and clinical usefulness. | Wolff, K.; Farrell, M.; Marsden, J.; Monteiro, M.; Ali, R.; Welch, S.; Strang, J. |
| 1999 | A study on the seasonal variation in the development of morphine dependence in rats. | Salem, A.; Hope, W. |
| 2015 | A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone | Peacock, A.; Degenhardt, L.; Larance, B.; Cama, E.; Lintzeris, N.; Ali, R.; Bruno, R. |
| 1995 | Abasic sites stimulate double-stranded DNA cleavage mediated by topoisomerase II | Kingma, Paul S.; Corbett, Anita H.; Burcham, Philip Cyril; Marnett, Lawrence J.; Osheroff, Neil |
| 2006 | ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals | Coller, J.; Barratt, D.; Dahlen, K.; Loennechen, M.; Somogyi, A. |
| 2012 | ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics | Barratt, D.; Coller, J.; Hallinan, R.; Byrne, A.; White, J.; Foster, D.; Somogyi, A. |
| 1996 | Absorption and excretion of the soy isoflavone genistein in the rat. | King, R.; Broadbent, J.; Head, R. |
